Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cells

Written By Mollie Rotmensch

Chen H. et al. J. Immunother. Cancer. 2020; doi: 10.1136/jitc-2019-000515.

Mollie Rotmensch
Previous

LILRB4-targeting antibody-drug conjugates for the treatment of acute myeloid leukemia

Next

Phagocytosis checkpoints as new targets for cancer immunotherapy